LifeVantage Corporation

    Jurisdiction
    United States
    LEI
    5493001Z5YYT109QZ980
    ISIN
    US53222K2050 (LFVN)
    Sectors
    1. Consumer Defensive
    2. Packaged Foods

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €17.39 117.3% undervalued
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. Read full profile

    Fundamentals

    Net revenue
    €194.92M
    Gross margin
    80.4%
    EBIT
    €10.41M
    EBIT margin
    5.3%
    Net income
    €8.36M
    Net margin
    4.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €197.86M +1.5% €10.72M +28.2%
    €207.27M +4.8% €11.97M +11.6%
    €218.01M +5.2% €11.60M -3.1%

    Products

    Product Revenue
    Protandim €95.33M 48.9%
    Lifevantage Truescience Skin Care Regimen €56.23M 28.8%
    Product And Service, Other €5.73M 2.9%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.05
    Ex date
    Payment date
    Dividend payout ratio
    21.1%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 864K $12.60M +83K Buy

    Earnings Calls

    Latest earnings call: May 3, 2024 (Q3 2024)

    Add to watchlist

    Notifications